Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Beer

Showing results (21-30 of 176) with videos related to

Pageof 18
Sort By:
Gastroenterology|May 8, 2004
Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitorMasood A Shammas, Hemanta Koley, David G Beer, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 20, 2007
STAT5 mediates PAF-induced NADPH oxidase NOX5-S expression in Barrett's esophageal adenocarcinoma cellsJin Si, Jose Behar, Jack Wands, et al.
International Journal of Proteomics|November 18, 2011
Signatures of drug sensitivity in nonsmall cell lung cancerHua C Gong, Sean Wang, Gary Mayer, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 22, 2015
The role of Dickkopf-3 overexpression in esophageal adenocarcinomaZhuwen Wang, Lin Lin, Dafydd G Thomas, et al.
Cell Death & Disease|March 7, 2024
Isoform alterations in the ubiquitination machinery impacting gastrointestinal malignanciesSrimathi Kasturirangan, Derek J Nancarrow, Ayush Shah, et al.
Cancer Cell|September 21, 2002
Transforming properties of a Q18-->E mutation of the microtubule regulator Op18David E Misek, Christina L Chang, Rork Kuick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2012
Integrative genomics identified RFC3 as an amplified candidate oncogene in esophageal adenocarcinomaWilliam W Lockwood, Kelsie L Thu, Lin Lin, et al.
Oncotarget|November 21, 2017
Identification and validation of FGFR2 peptide for detection of early Barrett's neoplasiaJuan Zhou, Lei He, Zhijun Pang, et al.
Carcinogenesis|February 14, 2004
The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosisJosé M Cuezva, Guoan Chen, Andrés M Alonso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinomaKhaled A Hassan, Luo Wang, Hasan Korkaya, et al.
Pageof 18

Showing results (21-30 of 176) with videos related to

Sort By:
Pageof 18
Gastroenterology|May 8, 2004
Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitorMasood A Shammas, Hemanta Koley, David G Beer, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 20, 2007
STAT5 mediates PAF-induced NADPH oxidase NOX5-S expression in Barrett's esophageal adenocarcinoma cellsJin Si, Jose Behar, Jack Wands, et al.
International Journal of Proteomics|November 18, 2011
Signatures of drug sensitivity in nonsmall cell lung cancerHua C Gong, Sean Wang, Gary Mayer, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 22, 2015
The role of Dickkopf-3 overexpression in esophageal adenocarcinomaZhuwen Wang, Lin Lin, Dafydd G Thomas, et al.
Cell Death & Disease|March 7, 2024
Isoform alterations in the ubiquitination machinery impacting gastrointestinal malignanciesSrimathi Kasturirangan, Derek J Nancarrow, Ayush Shah, et al.
Cancer Cell|September 21, 2002
Transforming properties of a Q18-->E mutation of the microtubule regulator Op18David E Misek, Christina L Chang, Rork Kuick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2012
Integrative genomics identified RFC3 as an amplified candidate oncogene in esophageal adenocarcinomaWilliam W Lockwood, Kelsie L Thu, Lin Lin, et al.
Oncotarget|November 21, 2017
Identification and validation of FGFR2 peptide for detection of early Barrett's neoplasiaJuan Zhou, Lei He, Zhijun Pang, et al.
Carcinogenesis|February 14, 2004
The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosisJosé M Cuezva, Guoan Chen, Andrés M Alonso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinomaKhaled A Hassan, Luo Wang, Hasan Korkaya, et al.
Pageof 18